This week, we highlight the results of innovation powered by collaboration, within Children’s Hospital of Philadelphia Research Institute and around the globe. A multicenter, international consortium revealed genes newly linked to epilepsy, while CHOP CEO Madeline Bell visited Dubai for an interchange of knowledge and technology at the largest medical conference in the world. Closer to home, the Children’s Hospitals’ Solutions for Patient Safety Network, comprised of 135 hospitals in the United States, published its findings on the most effective targets for pediatric patient safety research, and a high school intern helped researchers recruit participants for a teen driving study. Learn about the latest trends in pediatric opioid prescription, and get an update on the Delaney family, whose conjoined twin daughters were separated with painstaking care by a multidisciplinary team at CHOP.
Tag Archive: epilepsy
A new word is catching on to describe the sometimes overwhelming life stage of learning to behave like a grown-up: “adulting.” For youth with chronic diseases, adulting has complexities beyond coming to grips with doing their own laundry.
This week we’re all about getting smart in our highlights of research news from The Children’s Hospital of Philadelphia. Getting smart in the approach to tackling childhood cancer means identifying strategies that will make a decade’s progress in half the time.
A blizzard of research happenings and news — from initiatives that are pushing precision medicine forward to a new way of thinking about how cancer progresses — appear in the January issue of Bench to Bedside.
Neuroscientists worldwide celebrated the 20th Anniversary of Brain Awareness Week, March 16-22.
Neuroscience researcher Hajime Takano, PhD, who works in Douglas Coulter, PhD’s, epilepsy research laboratory at The Children’s Hospital of Philadelphia, is especially interested in which specific neurons could be inciting the neural network.
An international team of researchers recently identified gene mutations that can cause severe, difficult-to-treat forms of childhood epilepsy. Many of the mutations disrupt functioning in the synapse, the highly dynamic junction at which nerve cells communicate with one another.
A new study supports the idea that the identification of specific genetics targets could lead to a sea change in the way epilepsy is treated.
Most children with epilepsy can have active and fulfilling lives, with the help of modern therapies. Yet 20 percent to 30 percent of children with epilepsy do not respond to medications, which physicians call medication-resistant or intractable epilepsy.